IL81879A - Purification of minactivin for homogeneity, production of minactivin as recombinant techniques, and uses of homogeneous or recombinant minactivin - Google Patents

Purification of minactivin for homogeneity, production of minactivin as recombinant techniques, and uses of homogeneous or recombinant minactivin

Info

Publication number
IL81879A
IL81879A IL8187987A IL8187987A IL81879A IL 81879 A IL81879 A IL 81879A IL 8187987 A IL8187987 A IL 8187987A IL 8187987 A IL8187987 A IL 8187987A IL 81879 A IL81879 A IL 81879A
Authority
IL
Israel
Prior art keywords
minactivin
recombinant
dna
gaa
polypeptide
Prior art date
Application number
IL8187987A
Other languages
English (en)
Hebrew (he)
Original Assignee
Biotech Australia Pty Ltd
Univ Australian
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotech Australia Pty Ltd, Univ Australian filed Critical Biotech Australia Pty Ltd
Publication of IL81879A publication Critical patent/IL81879A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8132—Plasminogen activator inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/972—Plasminogen activators
    • G01N2333/9723—Urokinase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
IL8187987A 1986-03-13 1987-03-12 Purification of minactivin for homogeneity, production of minactivin as recombinant techniques, and uses of homogeneous or recombinant minactivin IL81879A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPH501786 1986-03-13
AUPH603386 1986-05-22
AUPH810086 1986-09-18
AUPH910486 1986-11-21

Publications (1)

Publication Number Publication Date
IL81879A true IL81879A (en) 1994-07-31

Family

ID=27424177

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8187987A IL81879A (en) 1986-03-13 1987-03-12 Purification of minactivin for homogeneity, production of minactivin as recombinant techniques, and uses of homogeneous or recombinant minactivin

Country Status (13)

Country Link
US (1) US5426044A (de)
EP (1) EP0238275B1 (de)
JP (2) JP2589996B2 (de)
KR (1) KR960001820B1 (de)
CN (2) CN1032019C (de)
AT (1) ATE132192T1 (de)
CA (1) CA1338381C (de)
DE (1) DE3751646T2 (de)
DK (2) DK172400B1 (de)
IL (1) IL81879A (de)
NO (1) NO178504C (de)
NZ (1) NZ219608A (de)
WO (1) WO1987005628A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923807A (en) * 1984-05-18 1990-05-08 New England Medical Center Hospitals Inc. Arg-Serpin human plasminogen activator inhibitor designated PAI-2
DK0446315T3 (da) * 1989-09-05 1998-01-05 Biotech Australia Pty Ltd Fremgangsmåde til fremstilling af PAI-2
AU625018B2 (en) * 1989-12-20 1992-06-25 Biotech Australia Pty Limited Variants of pai-2
GB9026737D0 (en) * 1990-12-08 1991-01-30 Delta Biotechnology Ltd Cancer treatment
US5994309A (en) 1997-07-25 1999-11-30 Angstrom Pharmaceuticals, Inc. Anti-invasive and anti-angiogenic compositions and methods
CN102586187A (zh) * 2012-02-23 2012-07-18 深圳市中美康士生物科技有限公司 一种中性粒细胞体外保存方法及培养基

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923807A (en) * 1984-05-18 1990-05-08 New England Medical Center Hospitals Inc. Arg-Serpin human plasminogen activator inhibitor designated PAI-2
JPH0655152B2 (ja) * 1984-08-13 1994-07-27 バイオテクノロジー・オーストラリア・ピーテイーワイ・リミテツド ミナクチビンの製造方法
CA1331355C (en) * 1986-04-21 1994-08-09 Bioenterprises Pty. Ltd Immunopotentation

Also Published As

Publication number Publication date
EP0238275B1 (de) 1995-12-27
ATE132192T1 (de) 1996-01-15
CA1338381C (en) 1996-06-11
KR960001820B1 (ko) 1996-02-05
DE3751646T2 (de) 1996-10-17
DK595187D0 (da) 1987-11-13
WO1987005628A1 (en) 1987-09-24
JP2660681B2 (ja) 1997-10-08
DK27097A (da) 1997-03-13
CN87102725A (zh) 1987-11-11
NO178504B (no) 1996-01-02
US5426044A (en) 1995-06-20
EP0238275A3 (en) 1989-05-10
JPH08112094A (ja) 1996-05-07
DK595187A (da) 1988-07-21
DE3751646D1 (de) 1996-02-08
NO874704D0 (no) 1987-11-11
CN1100957A (zh) 1995-04-05
NZ219608A (en) 1991-05-28
NO178504C (no) 1996-04-10
CN1032019C (zh) 1996-06-12
EP0238275A2 (de) 1987-09-23
JPS63503354A (ja) 1988-12-08
NO874704L (no) 1987-11-11
JP2589996B2 (ja) 1997-03-12
KR880701073A (ko) 1988-07-25
DK172400B1 (da) 1998-05-18

Similar Documents

Publication Publication Date Title
US4966849A (en) CDNA and genes for human angiogenin (angiogenesis factor) and methods of expression
EP0502968B1 (de) Aktivierbare fibrinolytische und antithrombotische proteine
EP0235162B1 (de) Cdns und gen für menschliches angiogenin (angiogenesis-faktor) und expression
CA2084514A1 (en) O-glycosylated ifn-alpha
US5332804A (en) High molecular weight human angiogenic basic fibroblast growth factors
JPH02121934A (ja) 組合せ医薬組成物
CA1341516C (en) Preparation of factor x111a by gene manipulation
JP2567536B2 (ja) Ｐａｉー２の変異体
WO1993016709A1 (en) Therapeutic domains of von willebrand factor
IE81116B1 (en) Hybrid plasminogen activators
IL81879A (en) Purification of minactivin for homogeneity, production of minactivin as recombinant techniques, and uses of homogeneous or recombinant minactivin
AU645055B2 (en) Covalent angiogenin/RNase hybrids
US5270204A (en) Covalent angiogenin/RNase hybrids
FI110669B (fi) Menetelmiä luonnosta eristettävissä tai synteettisesti valmistettavissa olevien trombiini-inhibiittorien valmistamiseksi
WO1993000357A1 (en) Therapeutic polypeptides based on von willebrand factor
AU608752B2 (en) Minactivin produced by recombinant dna technology
US5188943A (en) Method of producing high molecular weight human fibroblast growth factors
US5422090A (en) Human PAI-2
FI102844B (fi) Menetelmä valmistaa parannettu terapeuttisesti aktiivinen kudosplasmin ogeenin aktivaattori
AU3064989A (en) Modified gene sequences encoding modified tpa and products therefrom
EP0307478A1 (de) Serin-protease und serin-protease-gen
EP0495638A2 (de) Expression von reifem PDGF-B in Escherichia coli
JPH0757192B2 (ja) 新規なｄｎａ

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees